Quorum-sensing regulator sdiA and marA overexpression is involved in in vitro-selected multidrug resistance of Escherichia coli

Journal of Antimicrobial Chemotherapy

Volumn 65, Issue 6, 2010, Pages 1178-1186

  Tavío, María M ^a   Aquili, Virginia D ^a   Poveda, José B ^a   Antunes, Nuno T ^a   Sánchez Céspedes, Javier ^b   Vila, Jordi ^b  

^a UNIVERSITY OF LAS PALMAS DE GRAN CANARIA   (Spain)

^b UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Ceftazidime; Lomefloxacin; Multiresistant; Stress response

Indexed keywords

2,4 DINITROPHENOL; ACRB PROTEIN; AZTREONAM; BACTERIAL PROTEIN; BETA LACTAMASE; CEFALOTIN; CEFEPIME; CEFOXITIN; CEFPIROME; CEFTAZIDIME; CHLORAMPHENICOL; CYCLOHEXANE; FTSI PROTEIN; IMIPENEM; LOMEFLOXACIN; MARA PROTEIN; MEMBRANE PROTEIN; MITOMYCIN C; NALIDIXIC ACID; NORFLOXACIN; OUTER MEMBRANE PROTEIN; OUTER MEMBRANE PROTEIN F; PENICILLIN BINDING PROTEIN; PENICILLIN BINDING PROTEIN 3; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SDIA PROTEIN; SOXS PROTEIN; TETRACYCLINE; TOLC PROTEIN; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GROWTH; BACTERIUM ISOLATE; CONTROLLED STUDY; ENZYME ACTIVITY; ESCHERICHIA COLI; FRAMESHIFT MUTATION; GENE OVEREXPRESSION; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; NONHUMAN; PHENOTYPE; QUORUM SENSING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS;

2,4-DINITROPHENOL; ANTI-BACTERIAL AGENTS; BETA-LACTAMASES; CEFTAZIDIME; DNA-BINDING PROTEINS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ESCHERICHIA COLI; ESCHERICHIA COLI PROTEINS; FLUOROQUINOLONES; GENE EXPRESSION; GENE EXPRESSION PROFILING; HUMANS; MUTATION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SEQUENCE ANALYSIS, DNA; TRANS-ACTIVATORS; UNCOUPLING AGENTS; UP-REGULATION;

EID: 77953517647     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkq112     Document Type: Article

References (52)

1. Giske CG, Monnet DL, Cars O et al. Clinical and economic impact of common multidrug-resistant Gram-negative bacilli. Antimicrob Agents Chemother 2008; 52: 813-21.
2. Nicoloff H, Perreten V, Levy SB. Increased genome instability in Escherichia coli lon mutants: relation to emergence of multiple-antibiotic-resistant (Mar) mutants caused by insertion sequence elements and large tandem genomic amplifications. Antimicrob Agents Chemother 2007; 51: 1293-303.
3. White DG, Goldman JD, Demple B et al. Role of the acrAB locus in organic solvent tolerance mediated by expression of marA, soxS, or robA in Escherichia coli. J Bacteriol 1997; 179: 6122-6.
4. Alekshun MN, Levy SB. Regulation of chromosomally mediated multiple antibiotic resistance: the mar regulon. Antimicrob Agents Chemother 1997; 41: 2067-75.
5. Gallegos MT, Schleif R, Bairoch A et al. Aralc/XylS family of transcriptional regulators. Microbiol Mol Biol Rev 1997; 61: 397-410.
6. Ariza RR, Li Z, Ringstad N et al. Activation of multiple antibiotic resistance and binding of stress-inducible promoters by Escherichia coli Rob protein. J Bacteriol 1995; 177: 1655-61.
7. Aono R, Tsukagoshi N, Yamamoto M. Involvement of outer membrane protein TolC, a possible member of the mar-sox regulon, in maintenance and improvement of organic solvent tolerance of Escherichia coli K-12. J Bacteriol 1998; 180: 938-44.
8. Pomposiello PJ, Bennik MHJ, Demple B. Genome-wide transcriptional profiling of the Escherichia coli responses to superoxide stress and sodium salicylate. J Bacteriol 2001; 183: 3890-902.
9. Webber MA, Piddock LJV. Absence of mutations in marRAB or soxRS in acrB-overexpressing fluoroquinolone-resistant clinical and veterinary isolates of Escherichia coli. Antimicrob Agents Chemother 2001; 45: 1550-2.
10. Wang H, Dzink-Fox JL, Chen M et al. Genetic characterization of highly fluoroquinolone-resistant clinical Escherichia coli strains from China: role of acrR mutations. Antimicrob Agents Chemother 2001; 45: 1515-21.
11. Pumbwe L, Skilbeck CA, Wexler HM. Presence of quorum-sensing systems associated with multidrug resistance and biofilm formation in Bacteroides fragilis. Microbiol Ecol 2008; 56: 412-9.
12. Rahmati S, Yang S, Davidson AL et al. Control of the AcrAB multidrug efflux pump by quorum-sensing regulator SdiA. Mol Microbiol 2002; 43: 677-85.
13. Wei Y, Lee JM, Smulski DR et al. Global impact of sdiA amplification revealed by comprehensive gene expression profiling of Escherichia coli. J Bacteriol 2001; 183: 2265-72.
14. Yang S, López CR, Zechiedrich EL. Quorum sensing and multidrug transporters in Escherichia coli. Proc Natl Acad Sci USA 2006; 103: 2386-91.
15. Pesci EC, Milbank JBJ, Pearson JP et al. Quinolone signaling in the cell-to-cell communication system of Pseudomonas aeruginosa. Proc Natl Acad Sci USA 1999; 96: 11229-34.
16. Oethinger M, Kern WV, Jellen-Ritter AS et al. Ineffectiveness of topoisomerase mutations in mediating clinically significant fluoroquinolone resistance in Escherichia coli in the absence of the AcrAB efflux pump. Antimicrob Agents Chemother 2000; 44:10-3.
17. Ricci V, Tzakas P, Buckler A et al. Ciprofloxacin-resistant Salmonella enterica serovar Typhimurium strains are difficult to select in the absence of AcrB and TolC. Antimicrob Agents Chemother 2006; 50: 38-42.
18. National Committee for Clinical Laboratory Standards. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically-Seventh Edition: Approved Standard M7-A7. Wayne, PA, USA: NCCLS, 2006.
19. Yang S, Clayton SR, Zechiedrich EL. Relative contributions of the AcrAB, MdfA and NorE efflux pumps to quinolone resistance in Escherichia coli. J Antimicrob Chemother 2003; 51: 545-56.
20. Wei Y, Vollmer AC, LaRossa RA. In vitro titration of mitomycin C by four Escherichia coli genomic regions on multicopy plasmids. J Bacteriol 2001; 183: 2259-64.
21. Nicoloff H, Perreten V, McMurry LM et al. Role for tandem duplication and Lon protease in AcrAB-TolC-dependent multiple antibiotic resistance (Mar) in an Escherichia coli mutant without mutations in marRAB or acrRAB. J Bacteriol 2006; 188: 4413-23.
22. Corvec S, Prodhomme A, Giraudeau C et al. Most Escherichia coli strains overproducing chromosomal AmpC β-lactamase belong to phylogenetic group A. J Antimicrob Chemother 2007; 60: 872-6.
23. Song W, Bae I, Lee Y-N et al. Detection of extended-spectrum β-lactamases by using boronic acid as an AmpC β-lactamase inhibitor in clinical isolates of Klebsiella spp. and Escherichia coli. J Clin Microbiol 2007; 45: 1180-4.
24. Tavío MM, Perilli M, Vila J et al. Salicylate decreases production of AmpC type β-lactamases and increases susceptibility to b-lactams in a Morganella morganii clinical isolate. FEMS Microbiol Lett 2004; 238: 139-44.
25. Tavío MM, Vila J, Perilli M et al. Enhanced active efflux, repression of porin synthesis and development of Mar phenotype by diazepam in two enterobacteria strains. J Med Microbiol 2004; 53: 1119-22.
26. Zhao G, Meier TI, Kahl SD et al. Bocillin FL, a sensitive and commercially available reagent for detection of penicillin-binding-proteins. Antimicrob Agents Chemother 1999; 43: 1124-8.
27. Asako H, Nakajima H, Kobayashi K et al. Organic solvent tolerance and antibiotic resistance increased by overexpression of marA in Escherichia coli. Appl Environ Microbiol 1997; 63: 1428-33.
28. Kobayashi K, Tsukagoshi N, Aono R. Suppression of hypersensitivity of Escherichia coli acrAB mutant to organic solvents by integrational activation of the acrEF operon with the IS1 or IS2 element. J Bacteriol 2001; 183: 2646-53.
29. Sánchez-Céspedes J, Vila J. Partial characterization of the acrAB locus in two Citrobacter freundii clinical isolates. Int J Antimicrob Chemother 2007; 30: 250-63.
30. Kern WV, Oethinger M, Jellen-Ritter AS et al. Non-target gene mutations in the development of fluoroquinolone resistance in Escherichia coli. Antimicrob Agents Chemother 2000; 44: 814-20.
31. Michán C, Manchado M, Pueyo C. SoxRS down-regulation of rob transcription. J Bacteriol 2002; 184: 4733-8.
32. Eaves DJ, Ricci V, Piddock LJV. Expression of acrB, acrF, acrD, marA, and soxS in Salmonella enterica serovar Typhimurium: role in multiple antibiotic resistance. Antimicrob Agents Chemother 2004; 48: 1145-50.
33. Ruiz J, Casellas S, Jiménez de Anta MT et al. The region of the parE gene, homologous to the quinolone-resistant determining region of the gyrB gene, is not linked with the acquisition of quinolone resistance in Escherichia coli clinical isolates. J Antimicrob Chemother 1997; 39: 839-40.
34. Lindgren PK, Karlsson A, Hughes D. Mutation rate and evolution of fluoroquinolone resistance in Escherichia coli isolates from patients with urinary tract infections. Antimicrob Agents Chemother 2003; 47: 3222-32.
35. Gu R, Li M, Su CC et al. Conformational change of the AcrR regulator reveals a possible mechanism of induction. Acta Crystallogr Sect F Struct Biol Cryst Commun 2008; 64: 584-8.
36. Liao X, Hancock RE. Susceptibility to b-lactam antibiotics of Pseudomonas aeruginosa overproducing penicillin-binding-protein 3. Antimicrob Agents Chemother 1997; 41: 1158-61.
37. Nishino K, Yamada J, Hirakawa H et al. Roles of TolC-dependent multidrug transporters of Escherichia coli in resistance to b-lactams. Antimicrob Agents Chemother 2003; 47: 3030-3.
38. Martin RG, Bartlett ES, Rosner JL et al. Activation of the E. coli marA/soxS/rob regulon in response to transcriptional activator concentration. J Mol Biol 2008; 380: 278-84.
39. Linde H-J, Notka F, Metz M et al. In vivo increase in resistance to ciprofloxacin in Escherichia coli associated with deletion of the C-terminal part of MarR. Antimicrob Agents Chemother 2000; 44: 1865-8.
40. Corvec S, Lepelletier D, Reynaud A et al. In vivo selection of an Escherichia coli isolate highly resistant to ciprofloxacin and ceftazidime: role of a 4-bp duplication in acrR and ampC overexpression. Int J Antimicrob Agents 2008; 32: 196-8.
41. Griffith KL, Shah IM, Wolf RE. Proteolytic degradation of Escherichia coli transcription activators SoxS and MarA as the mechanism for reversing the induction of the superoxide (SoxRS) and multiple antibiotic resistance (Mar) regulons. Mol Microbiol 2004; 51: 1801-16.
42. Wang XD, de Boer PA, Rothfield LI. A factor that positively regulates cell division by activating transcription of the major cluster of essential cell division genes of Escherichia coli. EMBO J 1991; 10: 3363-72.
43. Sitnikov D, Schineller JB, Baldwin TO. Control of cell division in Escherichia coli: regulation of transcription of ftsQA involves both rpoS and SdiA-mediated autoinduction. Proc Natl Acad Sci USA 1996; 93: 336-41.
44. Lee J, Jayaraman A, Wood TK. Indole is an inter-species biofilm signal mediated by SdiA. BMC Microbiol 2007; 7: 42.
45. Lee A, Mao W, Warren MS et al. Interplay between efflux pumps may provide either additive or multiplicative effects on drug resistance. J Bacteriol 2000; 182: 3142-50.
46. Jacoby GA, Sutton L. β-lactamases and b-lactam resistance in Escherichia coli. Antimicrob Agents Chemother 1985; 28: 703-5.
47. Tavío-Pérez MM, Amicosante G, Franceschini N et al. Decreased production of AmpC-type β-lactamases associated with the development of resistance to quinolones in Citrobacter freundii strains. Microb Drug Resist 1999; 5: 235-40.
48. Stapleton PD, Shannon KP, French GL. Carbapenem resistance in Escherichia coli associated with plasmid-determined CMY-4 β-lactamase production and loss of an outer membrane protein. Antimicrob Agents Chemother 1999; 43: 1206-10.
49. Yoshimura F, Nikaido H. Diffusion of b-lactam antibiotics through the porin channels of Escherichia coli K-12. Antimicrob Agents Chemother 1985; 27: 84-92.
50. Maejima T, Inoue M, Mitsuhashi S. In vitro antibacterial activity of KP-736, a new cephem antibiotic. Antimicrob Agents Chemother 1991; 35: 104-10.
51. Curtis NAC, Orr D, Ross GW et al. Competition of b-lactam antibiotics for the penicillin-binding-proteins of Pseudomonas aeruginosa, Enterobacter cloacae, Klebsiella aerogenes, Proteus rettgeri, and Escherichia coli: comparison with antibacterial activity and effects upon bacterial morphology. Antimicrob Agents Chemother 1979; 16: 325-8.
52. Georgopapadakou NH. Penicillin-binding proteins and bacterial resistance to b-lactams. Antimicrob Agents Chemother 1993; 37: 2045-53.